Acquiring Company
Schneider Electric
Acquired Company
PTC Therapeutics
Description
Schneider Electric has announced an agreement to acquire PTC Inc. in an all-cash deal valued at $205 per share. Following the announcement, shares of PTC saw a surge of over 33%. This acquisition aims to enhance Schneider Electric's capabilities in product lifecycle management and industrial IoT.
Fundz sees it the moment Schneider Electric makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired PTC Therapeutics?
PTC Therapeutics was acquired by Schneider Electric, based in Ile De France. The deal was reported on October 5, 2026. Schneider Electric is a multinational corporation specializing in energy management and automation solutions. Schneider Electric is privately held and operates in Energy.
When did Schneider Electric acquire PTC Therapeutics?
Schneider Electric's acquisition of PTC Therapeutics was reported on October 5, 2026. Schneider Electric has announced an agreement to acquire PTC Inc. in an all-cash deal valued at $205 per share. Following the announcement, shares of PTC saw a surge of over 33%. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does PTC Therapeutics do?
PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs. It is publicly traded (PTCT), operating in Biotechnology, and is based in South Plainfield.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.